0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Clopidogrel"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$6,499USDGBP
ZONTIVITY Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

ZONTIVITY Market Size, Forecast, and Market Insight - 2032

  • Report
  • March 2024
  • 30 Pages
  • Global
From
EUR$2,750USDGBP
From
EUR$7,500USDGBP
Ischemic Stroke Market and Forecast Analysis 2024 - Product Thumbnail Image

Ischemic Stroke Market and Forecast Analysis 2024

  • Drug Pipelines
  • January 2019
  • 163 Pages
  • Global
From
EUR$22,000USDGBP
Plavix - Product Thumbnail Image

Plavix

  • Report
  • July 2018
  • 27 Pages
  • Global
From
EUR$10,000USDGBP
EUR$236USDGBP
EUR$316USDGBP
From
EUR$950USDGBP
Loading Indicator

Clopidogrel is a cardiovascular drug used to prevent blood clots in people with certain conditions, such as coronary artery disease, peripheral artery disease, and stroke. It works by blocking the action of certain natural substances that can cause blood clots. Clopidogrel is available in both generic and brand-name forms. It is usually taken once a day, with or without food. Clopidogrel is a widely used drug in the cardiovascular market, with many generic and brand-name versions available. It is often prescribed in combination with other drugs, such as aspirin, to reduce the risk of stroke and heart attack. It is also used to prevent blood clots in people with certain conditions, such as atrial fibrillation. Some companies in the clopidogrel market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Other companies include Dr. Reddy's Laboratories, Lupin Pharmaceuticals, and Apotex. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more